Jeffrey C. Thompson

Also affiliated with Philadelphia University

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Clinical Validation of a Cell-Free DNA Fragmentome Assay for Augmentation of Lung Cancer Early Detection”.

Clinical Validation of a Cell-Free DNA Fragmentome Assay for Augmentation of Lung Cancer Early Detection

Cancer Discovery(2024)10.1158/2159-8290.cd-24-0519

N/A

0.657DataRank · unranked

79 citations

Peter B. Bach, Jacob Carey, Caitlin A. Schonewolf, Katalin Bognar, Manmeet S. Ahluwalia +33 more

Gene signature of antigen processing and presentation machinery (APM) as highly predictive of response to checkpoint blockade in lung cancer and melanoma.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.3121

N/A

0DataRank · unranked

2 citations

Christiana Davis, Wei‐Ting Hwang, Charuhas Deshpande, Seth Jeffries, Corey J. Langer +2 more

Combining radiomic phenotypes of non-small cell lung cancer with liquid biopsy data may improve prediction of response to EGFR inhibitors

Scientific Reports(2021)10.1038/s41598-021-88239-y

N/A

0DataRank · unranked

31 citations

Michael J. LaRiviere, Eric A. Cohen, Thomas H. Buckingham, Stephanie S. Yee, Taylor A. Black +9 more

Impact of Interobserver Variability in Manual Segmentation of Non-Small Cell Lung Cancer (NSCLC) Applying Low-Rank Radiomic Representation on Computed Tomography

Cancers(2021)10.3390/cancers13235985

N/A

0DataRank · unranked

21 citations

Bardia Yousefi, Lacey Serletti, Maya Galperin-Aizenberg, Leonid Roshkovan, José Marcio Luna +6 more

Plasma Genotyping at the Time of Diagnostic Tissue Biopsy Decreases Time-to-Treatment in Patients With Advanced NSCLC—Results From a Prospective Pilot Study

JTO Clinical and Research Reports(2022)10.1016/j.jtocrr.2022.100301

N/A

0DataRank · unranked

34 citations

Charu Aggarwal, Janeline Wong, Vivek Nimgaonkar, Wei‐Ting Hwang, Michelle Andronov +17 more

Development of a robust radiomic biomarker of progression-free survival in advanced non-small cell lung cancer patients treated with first-line immunotherapy

Scientific Reports(2022)10.1038/s41598-022-14160-7

N/A

0DataRank · unranked

24 citations

Hannah Horng, Leonid Roshkovan, Joanna K. Weeks, Michelle Hershman, Peter B. Noël +11 more

Are radiomic signatures ready for incorporation in the clinical pipeline?

Filmcritica(2023)10.21037/tlcr-23-502

N/A

0DataRank · unranked

0 citations

Leonid Roshkovan, Jeffrey C. Thompson, Despina Kontos, Sharyn I. Katz, Apurva Singh

Gene signature of antigen processing and presentation machinery predicts response to checkpoint blockade in non-small cell lung cancer (NSCLC) and melanoma

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2020-000974

N/A

0DataRank · unranked

117 citations

Christiana Davis, Charuhas Deshpande, Wei‐Ting Hwang, Seth Jeffries, Alexander C. Huang +4 more

University of Pennsylvania Telehealth Research Center of Excellence

JNCI Monographs(2024)10.1093/jncimonographs/lgae011

N/A

0DataRank · unranked

1 citations

Charų C. Aggarwal, Sarah Beucker, David W. Dougherty, Peter Gabriel, Linda A. Jacobs +42 more